Dogwood Therapeutics
DWTX
23 hedge funds and large institutions have $307K invested in Dogwood Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 5 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
0.1% less ownership
Funds ownership: 0.28% → 0.18% (-0.1%)
0% less capital invested
Capital invested by funds: $308K → $307K (-$518)
8% less funds holding
Funds holding: 25 → 23 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$51.5K |
| 2 |
Jane Street
New York
|
+$5.74K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$4.01K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$3.65K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$3.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$59.5K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$40.7K |
| 3 |
Walleye Capital
New York
|
-$38.8K |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$27.1K |
| 5 |
Koshinski Asset Management
Decatur,
Illinois
|
-$9.66K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
26
Two Sigma Securities
New York
| – | -$4.85K | -822 | Closed |
|
|
VF
27
Virtu Financial
New York
| – | -$4K | -671 | Closed |
|
28
Citadel Advisors
Miami,
Florida
| – | -$1 | – | – |
|
29
Morgan Stanley
New York
| – | -$3 | – | – |
|
DWTX Hedge Fund Activity: Q1 2023 in Review
23 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q1 2023, worth a combined $307K — down 0.17% from $308K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of DWTX and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $51.5K. The largest seller was Renaissance Technologies, cutting an estimated $59.5K.
- 23 institutional investors held Dogwood Therapeutics (DWTX) as of Q1 2023, down from 25 in Q4 2022.
- Funds reported $307K of Dogwood Therapeutics stock for Q1 2023, down 0.17% quarter-over-quarter.
- 3 funds opened new Dogwood Therapeutics positions in Q1 2023 and 5 closed out, a net change of -2 holders.
- The largest Dogwood Therapeutics buyer in Q1 2023 was Susquehanna International Group, an estimated $51.5K added.
- The largest Dogwood Therapeutics seller in Q1 2023 was Renaissance Technologies, an estimated $59.5K sold.
Based on aggregated 13F filings for Q1 2023.